project id: TCGA-BLCA; case submitter id: TCGA-KQ-A41Q; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.2; age at index: 89; days to birth: -32511; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1920; age at diagnosis: 32511; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 361.0; icd 10 code: C67.3; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Anterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 480.0; sample id: a52db352-836e-4ba4-8f84-4760e4bf0e39; sample submitter id: TCGA-KQ-A41Q-01A; portion id: 895b8d91-98fc-44ee-bad1-5c2701ddeae3; portion submitter id: TCGA-KQ-A41Q-01A-11; slide id: 71977a32-e534-4f75-8f5d-b4dbe22f184c; slide submitter id: TCGA-KQ-A41Q-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; section location: TOP;